183 related articles for article (PubMed ID: 24607565)
1. From sheep to mice to cells: tools for the study of the sphingolipidoses.
Zigdon H; Meshcheriakova A; Futerman AH
Biochim Biophys Acta; 2014 Aug; 1841(8):1189-99. PubMed ID: 24607565
[TBL] [Abstract][Full Text] [Related]
2. Gene Therapy of Sphingolipid Metabolic Disorders.
Shaimardanova AA; Solovyeva VV; Issa SS; Rizvanov AA
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835039
[TBL] [Abstract][Full Text] [Related]
3. Molecular facets of sphingolipids: mediators of diseases.
Ozbayraktar FB; Ulgen KO
Biotechnol J; 2009 Jul; 4(7):1028-41. PubMed ID: 19579220
[TBL] [Abstract][Full Text] [Related]
4. The biochemistry of sphingolipid storage diseases.
Sandhoff K
Angew Chem Int Ed Engl; 1977 May; 16(5):273-85. PubMed ID: 406814
[No Abstract] [Full Text] [Related]
5. Rare Diseases in Glycosphingolipid Metabolism.
Zhou H; Wu Z; Wang Y; Wu Q; Hu M; Ma S; Zhou M; Sun Y; Yu B; Ye J; Jiang W; Fu Z; Gong Y
Adv Exp Med Biol; 2022; 1372():189-213. PubMed ID: 35503182
[TBL] [Abstract][Full Text] [Related]
6. Concentrations of an activator protein for sphingolipid hydrolysis in liver and brain samples from patients with lysosomal storage diseases.
Inui K; Wenger DA
J Clin Invest; 1983 Nov; 72(5):1622-8. PubMed ID: 6415115
[TBL] [Abstract][Full Text] [Related]
7. Innate immune responses in the brain of sphingolipid lysosomal storage diseases.
Vitner EB; Futerman AH; Platt N
Biol Chem; 2015 Jun; 396(6-7):659-67. PubMed ID: 25720063
[TBL] [Abstract][Full Text] [Related]
8. LC-MS/MS multiplex analysis of lysosphingolipids in plasma and amniotic fluid: A novel tool for the screening of sphingolipidoses and Niemann-Pick type C disease.
Pettazzoni M; Froissart R; Pagan C; Vanier MT; Ruet S; Latour P; Guffon N; Fouilhoux A; Germain DP; Levade T; Vianey-Saban C; Piraud M; Cheillan D
PLoS One; 2017; 12(7):e0181700. PubMed ID: 28749998
[TBL] [Abstract][Full Text] [Related]
9. The sphiningolipidoses: an overview.
West HH
Postgrad Med; 1977 Mar; 61(3):90-3, 95. PubMed ID: 402652
[TBL] [Abstract][Full Text] [Related]
10. My journey into the world of sphingolipids and sphingolipidoses.
Sandhoff K
Proc Jpn Acad Ser B Phys Biol Sci; 2012; 88(10):554-82. PubMed ID: 23229750
[TBL] [Abstract][Full Text] [Related]
11. Lysosomal Ceramide Metabolism Disorders: Implications in Parkinson's Disease.
Paciotti S; Albi E; Parnetti L; Beccari T
J Clin Med; 2020 Feb; 9(2):. PubMed ID: 32098196
[TBL] [Abstract][Full Text] [Related]
12. Clinical and biochemical pathophysiology of ataxia in the sphingolipidoses.
Philippart M
Adv Neurol; 1978; 21():131-49. PubMed ID: 104554
[TBL] [Abstract][Full Text] [Related]
13. Lipid storage disease: Part II. Ultrastructural pathology of lipid storage cells in sphingolipidoses.
Takahashi K; Naito M
Acta Pathol Jpn; 1985 Mar; 35(2):385-408. PubMed ID: 2992227
[TBL] [Abstract][Full Text] [Related]
14. The expanding boundaries of sphingolipid lysosomal storage diseases; insights from Niemann-Pick disease type C.
Platt FM
Biochem Soc Trans; 2023 Oct; 51(5):1777-1787. PubMed ID: 37844193
[TBL] [Abstract][Full Text] [Related]
15. Sphingolipidoses in Turkey.
Ozkara HA; Topçu M
Brain Dev; 2004 Sep; 26(6):363-6. PubMed ID: 15275696
[TBL] [Abstract][Full Text] [Related]
16. Cancer and sphingolipid storage disease therapy using novel synthetic analogs of sphingolipids.
Gatt S; Dagan A
Chem Phys Lipids; 2012 May; 165(4):462-74. PubMed ID: 22387097
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in the biochemistry of sphingolipidoses.
Kolter T; Sandhoff K
Brain Pathol; 1998 Jan; 8(1):79-100. PubMed ID: 9458169
[TBL] [Abstract][Full Text] [Related]
18. [Activator protein for the enzymic hydrolysis of sphingolipids and their relationships to sphingolipidosis. Special reference to the catabolism of GM2 ganglioside].
Hirabayashi Y; Li YT; Li SC
Seikagaku; 1983; 55(1):1-13. PubMed ID: 6405000
[No Abstract] [Full Text] [Related]
19. [Phenotypes in heteroglycanoses and sphingolipidoses (author's transl)].
Gehler J
Monatsschr Kinderheilkd; 1981 Nov; 129(11):610-20. PubMed ID: 6798422
[TBL] [Abstract][Full Text] [Related]
20. Lipid storage disease: Part III. Ultrastructural evaluation of cultured fibroblasts in sphingolipidoses.
Takahashi K; Naito M; Suzuki Y
Acta Pathol Jpn; 1987 Feb; 37(2):261-72. PubMed ID: 3037847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
